Sort by
Refine Your Search
-
Listed
-
Category
-
Country
-
Field
-
biological basis, through technological processes and mathematical support. Your profile We are looking for a candidate with proficiency and documented research experience particularly in immunology and/or
-
of the selection process, candidates will be asked to submit their preference regarding research groups they would like to work with, which may be identical or different from the original choice indicated in
-
University of North Carolina at Chapel Hill | Chapel Hill, North Carolina | United States | about 2 months ago
techniques and approaches to difference image analysis, survey-scale photometric calibration and detrending, periodicity searches, and/or other areas. A negotiable fraction of this role is reserved
-
University of North Carolina at Chapel Hill | Chapel Hill, North Carolina | United States | 14 days ago
techniques and approaches to difference image analysis, survey-scale photometric calibration and detrending, periodicity searches, and/or other areas. A negotiable fraction of this role is reserved
-
funded by the European Commission as a Horizon Europe Research and Innovation Action (RIA), (HORIZON-HLTH-2021-TOOL-06). Genegut has 9 partners from 8 different European countries. The consortium includes
-
making a difference to people's lives. We believe that inspiring our people to do outstanding things at Durham enables Durham people to do outstanding things in the world. Being a part of Durham is about
-
University of North Carolina at Chapel Hill | Chapel Hill, North Carolina | United States | about 21 hours ago
Associate position involves laboratory research in biomedical science. The position studies focus on an animal model of arthritis and include in vivo studies (muscles and behavioral analyses, imaging
-
employees and 43,000 students work to create knowledge for a better world. You can find more information about working at NTNU and the application process here . ... (Video unable to load from YouTube. Accept
-
) quantification tools, holding back early immunogenicity risk assessment in the context of protein drug development. A clearer understanding of the rules governing T cell activation would form a paradigm shift in
-
paradigm shift in development of Biologics. A critical challenge preventing this is the current limiting volume of high quality and well-characterized in-vitro T cell immunogenicity data. In this project, we